http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101611004-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2013-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101611004-B1 |
| titleOfInvention | Composition for diagnosis of leukemia using TrkA |
| abstract | The present invention provides a method for diagnosing a leukemia comprising the step of measuring an mRNA level of a gene encoding TrkA or a level of a protein expressed therefrom, measuring the mRNA level of the TrkA gene or the level of the protein expressed therefrom A method for screening a substance capable of lowering the mRNA level of the TrkA gene or a substance capable of lowering the level of the protein expressed therefrom, and a method for screening an agent for preventing or treating leukemia, Or inhibiting the activity of a protein expressed from the gene. The present invention also relates to a pharmaceutical composition for preventing or treating leukemia. The use of the TrkA gene of the present invention not only can diagnose various types of leukemia but also inhibits the onset of leukemia, it can be widely used for prevention or treatment of leukemia. |
| priorityDate | 2013-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 345.